Concord Medical Services Files 6-K, Updates Office Address
Ticker: CCM · Form: 6-K · Filed: Feb 20, 2024 · CIK: 1472072
| Field | Detail |
|---|---|
| Company | Concord Medical Services Holdings Ltd (CCM) |
| Form Type | 6-K |
| Filed Date | Feb 20, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, administrative, address-change
TL;DR
**Concord Medical Services just filed a routine 6-K, updating their official business address in Beijing.**
AI Summary
Concord Medical Services Holdings Ltd, a foreign private issuer, filed a Form 6-K with the SEC on February 20, 2024. This filing indicates that the company submits annual reports under Form 20-F. The report, with Commission File Number 001-34563, updates its principal executive office address to Room 2701-05, Tower A, Global Trade Center, 36 North Third Ring Road East, Dongcheng District, Beijing 100013, People's Republic of China.
Why It Matters
This filing provides updated administrative information for Concord Medical Services, ensuring regulatory compliance and transparency for investors regarding its operational base.
Risk Assessment
Risk Level: low — This 6-K filing is purely administrative, updating contact information, and does not contain any information that would indicate a change in the company's financial or operational risk profile.
Key Players & Entities
- Concord Medical Services Holdings Ltd (company) — filer of the 6-K
- February 2024 (date) — month of report
- 001-34563 (other) — Commission File Number
- Beijing (location) — location of principal executive office
- People's Republic of China (location) — country of principal executive office
FAQ
What type of SEC filing is this document?
This document is a Form 6-K, a 'Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 Under the Securities Exchange Act of 1934'.
When was this 6-K filed?
The 6-K was filed on February 20, 2024, and the conformed period of report is also February 20, 2024.
What is the Commission File Number for Concord Medical Services Holdings Limited?
The Commission File Number for Concord Medical Services Holdings Limited is 001-34563.
What is the updated principal executive office address for Concord Medical Services Holdings Limited?
The updated principal executive office address is Room 2701-05, Tower A, Global Trade Center, 36 North Third Ring Road East, Dongcheng District, Beijing 100013, People's Republic of China.
Does Concord Medical Services Holdings Limited file annual reports under Form 20-F or Form 40-F?
Concord Medical Services Holdings Limited indicates by check mark that it files annual reports under cover of Form 20-F.
Filing Stats: 198 words · 1 min read · ~1 pages · Grade level 15.1 · Accepted 2024-02-20 07:30:26
Filing Documents
- tm246609d1_6k.htm (6-K) — 11KB
- tm246609d1_ex99-1.htm (EX-99.1) — 9KB
- 0001104659-24-025215.txt ( ) — 21KB
From the Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2024 Commission File Number: 001-34563 CONCORD MEDICAL SERVICES HOLDINGS LIMITED Room 2701-05, Tower A, Global Trade Center 36 North Third Ring Road East, Dongcheng District Beijing 100013 People’s Republic of China (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. CONCORD MEDICAL SERVICES HOLDINGS LIMITED By: /s/ Jianyu Yang Name: Jianyu Yang Title: Chairman and Chief Executive Officer Date: February 20, 2024 Exhibit Index Exhibit No. Description 99.1 Press Release